OrbusNeich Alleges Boston Scientific Infringes Some Of Its EU Stent Patents

OrbusNeich alleges that Boston Scientific has infringed two European patents covering certain novel stent designs. It claims two patents are infringed by several of Boston Scientific’s coronary stent systems, including the “PROMUS Element™”, “PROMUS Element™ Plus”, “OMEGA™ PtCr”, and “TAXUS™ Element™”.

OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands (via PR Newswire)

FORT LAUDERDALE, Fla., Feb. 20, 2013 /PRNewswire/ — OrbusNeich today announced that OrbusNeich Medical GmbH and Orbus International B.V., subsidiaries of OrbusNeich Medical, Inc., (collectively, “OrbusNeich”) have commenced patent infringement actions in Germany and The Netherlands against Boston…

published: February 20, 2013 in: Boston Scientific, Cardio, News

Most read

Latest

^